Centro Integral Médico SJR SC

Querétaro 76800

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease

Studies at this site

• A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma — Completed